Skip to main content
C

COCHLEAR LIMITED — Investor Relations & Filings

Ticker · COH ISIN · AU000000COH5 LEI · 5493001OLLWY8KV5UC08 ASX Manufacturing
Filings indexed 1,424 across all filing types
Latest filing 2020-04-06 Regulatory Filings
Country AU Australia
Listing ASX COH

About COCHLEAR LIMITED

https://www.cochlear.com

Cochlear Limited designs, manufactures, and distributes implantable hearing solutions for individuals with moderate to profound hearing loss. The product suite includes cochlear implants, bone conduction systems, and acoustic implants, notably the Nucleus and Baha product lines. These technologies are engineered to bypass damaged parts of the ear to provide direct stimulation to the hearing nerve or bone. The company emphasizes research and development to advance sound processing capabilities, wireless integration, and miniaturization of components. Serving a global demographic from pediatric to geriatric patients, the organization provides long-term support and upgrades for its systems. Its focus remains on delivering high-performance hearing outcomes and enhancing the communication abilities of its recipients through technological innovation and clinical collaboration.

Recent filings

Filing Released Lang Actions
Temporary pay reduction for Board, CEO & senior executives 1
Regulatory Filings
2020-04-06 English
Becoming a substantial holder 9 pages 237.7KB
Regulatory Filings
2020-04-01 English
Cochlear Share Purchase Plan Offer Open 22 pages 368.2KB
Regulatory Filings
2020-03-31 English
Cleansing Notice under Section 708A(5)(e) of the Corporation 1
Regulatory Filings
2020-03-30 English
Appendix 2A 15 pages 262.0KB
Regulatory Filings
2020-03-29 English
Appendix 3B - Update to Proposed Issue of Securities - COH 48 pages 634.5KB
Regulatory Filings
2020-03-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.